Top 3 drugs expected in first half of 2020
A new class of drugs for high cholesterol and a novel peanut allergy treatment lead expected approvals.
Read more
 
FDA clears landmark peanut allergy drug Palforzia
Global market for peanut allergy treatments estimated at $4.5 billion.
Read more
 
EDITOR'S PICK
Blockbuster diabetes drug snags new heart indication
Ozempic’s approval follows Jardiance’s expanded heart indication last July.
Read more